Garen Bohlin, Director at Tetraphase, holds 0.00 shares in Tetraphase (Ticker: TTPH), holds 52.47K shares in Collegium Pharmaceutical (Ticker: COLL), holds 45.14K shares in Karyopharm Therapeutics (Ticker: KPTI). Most recently, Garen Bohlin ― shares of Tetraphase on ― for an estimated value of ―.